NCT07217743View on ClinicalTrials.gov

Assess Impact of Poly-L-lactic Acid on GLP1 Subjects

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 27, 2025

Primary Completion Date

August 30, 2026

Study Completion Date

October 31, 2026

Conditions
Laxity; Skin
Interventions
DEVICE

Sculptra Aesthetic

15 GLP1 subjects treated with Sculptra to their abdomen for skin laxity will be compared to 5 non GLP1 subjects treated with Sculptra for skin laxity.

Trial Locations (1)

92121

West Dermatology Research Center, San Diego

All Listed Sponsors
lead

Goldman, Butterwick, Fitzpatrick and Groff

OTHER

NCT07217743 - Assess Impact of Poly-L-lactic Acid on GLP1 Subjects | Biotech Hunter | Biotech Hunter